From: Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study
95% CI** | |||||||
---|---|---|---|---|---|---|---|
Drugs | N (%) | Lower (%) | Upper (%) | Males (total %) | Females (total %) | % of patients ≤ 65 yrs | % of patients ≥ 65 yrs |
≤ 24 hours*** | |||||||
ASS | 92 (82%) | 70.7 | 86.8 | 82% | 83% | 77% | 87% |
β-Blockers | 72 (73%) | 63.1 | 80.8 | 72% | 75% | 71% | 74% |
at discharge | |||||||
ASS | 95 (85%) | 78.5 | 91.4 | 84% | 86% | 79% | 90% |
β-Blockers | 99 (79%) | 65.6 | 82.4 | 75% | 88% | 73% | 85% |
ACE Inhibitors/AR Blockers | 78 (66%) | 57.6 | 74.6 | 62% | 75% | 64% | 68% |
Lipid-lowering drugs | 52 (43%) | 34.4 | 52.2 | 35% | 54% | 47% | 40% |